The New Zealand Neuromuscular Disease Registry

Area of Science:

• Neurology
• Clinical Research
• Patient Registries

Background:

• Developing effective treatments for neuromuscular diseases is hindered by small patient populations for clinical trials.
• Rare neuromuscular conditions face challenges in establishing evidence-based clinical practices due to limited patient data.

Purpose of the Study:

• To establish a unified registry for all neuromuscular conditions in New Zealand.
• To overcome patient recruitment difficulties in clinical trials for rare neuromuscular diseases.
• To enhance clinical practice and treatment development through comprehensive patient data.

Main Methods:

• Collaboration between the Muscular Dystrophy Association of New Zealand (MDA) and clinicians.
• Creation of a single, inclusive registry for all types of neuromuscular diseases.
• Systematic data collection and management for all registered patients.

Main Results:

• The New Zealand Neuromuscular Disease (NZ NMD) Registry has been established.
• The registry consolidates data for diverse neuromuscular conditions.
• It provides a valuable resource for research and clinical care.

Conclusions:

• The NZ NMD Registry offers a significant benefit to patients with neuromuscular diseases.
• The registry will aid clinicians in developing improved diagnostic and treatment strategies.
• This initiative represents a crucial step forward in managing rare neuromuscular disorders.